HAOHAI BIOTEC (06826) announced that the company did not implement any A-share buybacks in July 2025. As of July 31, 2025, the company has cumulatively repurchased 1.8324 million A-shares through centralized competitive trading, representing 0.79% of the company's total share capital of 233 million shares. The highest transaction price was 63.58 yuan per share, while the lowest was 49.25 yuan per share, with a total transaction value of 104 million yuan (excluding stamp tax, trading commissions, and other transaction costs).